International Conference on Medicinal Chemistry and Drug Discovery (ICMC-DD - 26)

This track focuses on the latest developments in medicinal chemistry, highlighting innovative synthetic methods and their applications. Researchers are invited to present their findings on novel compounds and their potential therapeutic effects.

This session will explore the pharmacological profiles of new drug candidates, including their mechanisms of action and therapeutic efficacy. Contributions that detail the pharmacokinetics and pharmacodynamics of these agents are particularly encouraged.

This track emphasizes the intersection of chemical biology and drug discovery, showcasing how biological insights can inform the design of new therapeutics. Presentations may include studies on biomolecular interactions and their implications for drug development.

This session will delve into the use of molecular modeling and computational techniques in the drug discovery process. Researchers are invited to share their methodologies and results in predicting drug interactions and optimizing lead compounds.

This track is dedicated to the exploration of structure-activity relationships (SAR) in medicinal chemistry. Presentations should focus on how modifications to chemical structures impact biological activity and therapeutic potential.

This session will cover the development and application of targeted therapies in the context of precision medicine. Contributions that discuss novel approaches to personalize treatment based on molecular profiling are highly encouraged.

This track will highlight recent advancements in drug formulation techniques, including novel delivery systems and formulation strategies. Researchers are invited to present their work on improving bioavailability and therapeutic outcomes.

This session aims to bridge the gap between laboratory research and clinical application in medicinal chemistry. Presentations should focus on successful case studies that illustrate the translation of research findings into therapeutic interventions.

This track will explore the role of natural products in the discovery of new therapeutic agents. Researchers are encouraged to present their findings on the isolation, characterization, and biological evaluation of bioactive compounds from natural sources.

This session will focus on the impact of emerging technologies, such as artificial intelligence and machine learning, on drug development processes. Contributions that demonstrate innovative applications of these technologies in medicinal chemistry are welcome.

This track will address the regulatory landscape surrounding drug discovery and development. Presentations should focus on the challenges and strategies for navigating regulatory requirements in bringing new drugs to market.